AU7717396A - Inactivation of pathogens using hydroxymethylamines - Google Patents
Inactivation of pathogens using hydroxymethylaminesInfo
- Publication number
- AU7717396A AU7717396A AU77173/96A AU7717396A AU7717396A AU 7717396 A AU7717396 A AU 7717396A AU 77173/96 A AU77173/96 A AU 77173/96A AU 7717396 A AU7717396 A AU 7717396A AU 7717396 A AU7717396 A AU 7717396A
- Authority
- AU
- Australia
- Prior art keywords
- hydroxymethylamines
- pathogens
- inactivation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002779 inactivation Effects 0.000 title 1
- XMYQHJDBLRZMLW-UHFFFAOYSA-N methanolamine Chemical class NCO XMYQHJDBLRZMLW-UHFFFAOYSA-N 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49647895A | 1995-06-29 | 1995-06-29 | |
US496478 | 1995-06-29 | ||
US52665895A | 1995-09-11 | 1995-09-11 | |
US526658 | 1995-09-11 | ||
PCT/US1996/011152 WO1997002028A1 (en) | 1995-06-29 | 1996-07-01 | Inactivation of pathogens using hydroxymethylamines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7717396A true AU7717396A (en) | 1997-02-05 |
Family
ID=27052134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77173/96A Abandoned AU7717396A (en) | 1995-06-29 | 1996-07-01 | Inactivation of pathogens using hydroxymethylamines |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0792146A1 (en) |
JP (1) | JPH10506927A (en) |
AU (1) | AU7717396A (en) |
BR (1) | BR9606454A (en) |
CA (1) | CA2198085A1 (en) |
WO (1) | WO1997002028A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
US6514987B1 (en) | 1997-01-06 | 2003-02-04 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6093725A (en) * | 1997-01-06 | 2000-07-25 | Cerus Corporation | Frangible compounds for pathogen inactivation |
EP1045704B1 (en) | 1998-01-06 | 2004-09-22 | Cerus Corporation | Methods for quenching pathogen inactivators in biological materials |
WO2001058496A1 (en) * | 2000-02-11 | 2001-08-16 | Allied Therapeutics Limited | System for the extracorporeal treatment of blood |
US6635679B2 (en) * | 2001-05-14 | 2003-10-21 | Akzo Nobel N.V. | Methods and compositions for inactivating viruses |
EP1469729B1 (en) * | 2002-01-18 | 2015-10-21 | Lonza AG | Virucidal disinfectant |
CA2585621C (en) | 2004-10-29 | 2015-12-15 | Cerus Corporation | Improved quenching methods for red blood cell inactivation process |
BRPI0911176B8 (en) | 2008-04-09 | 2021-05-25 | Cerus Corp | method of treating a red blood cell composition, red blood cell composition, and method of reducing dehydration in a red blood cell composition |
CN101885740B (en) * | 2009-05-11 | 2015-07-01 | 李坚 | New preparation method of herbicide glyphosate |
CN110317230B (en) * | 2018-03-30 | 2023-11-07 | 上海昇悦医药科技有限公司 | Phosphate derivatives and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3239415A (en) * | 1963-01-14 | 1966-03-08 | Upjohn Co | Methods of reducing virus titers in animals with adenine derivatives |
DE2135542A1 (en) * | 1971-07-16 | 1973-01-25 | Boehringer Mannheim Gmbh | Virustatic benzthiazole-2-thione derivs - active against both dna and rna viruses |
SU490824A1 (en) * | 1974-08-27 | 1975-11-05 | Институт полиомиелита и вирусных энцефалитов АМН СССР | Method of inactivating infectiousness of viruses |
US4337269A (en) * | 1979-07-23 | 1982-06-29 | Sutton Laboratories, Inc. | Preservative compositions |
JPS62195304A (en) * | 1986-02-24 | 1987-08-28 | Dainippon Ink & Chem Inc | Industrial antiseptic |
US4833165A (en) * | 1987-10-07 | 1989-05-23 | Louderback Allan Lee | Method of inactivating HTLV-III virus in blood |
-
1996
- 1996-07-01 CA CA002198085A patent/CA2198085A1/en not_active Abandoned
- 1996-07-01 JP JP9505265A patent/JPH10506927A/en active Pending
- 1996-07-01 BR BR9606454A patent/BR9606454A/en not_active Application Discontinuation
- 1996-07-01 EP EP96940235A patent/EP0792146A1/en not_active Withdrawn
- 1996-07-01 WO PCT/US1996/011152 patent/WO1997002028A1/en not_active Application Discontinuation
- 1996-07-01 AU AU77173/96A patent/AU7717396A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997002028A1 (en) | 1997-01-23 |
JPH10506927A (en) | 1998-07-07 |
CA2198085A1 (en) | 1997-01-23 |
EP0792146A1 (en) | 1997-09-03 |
BR9606454A (en) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2041195A (en) | Process of sterilization | |
AU7419096A (en) | Treatment of vegetables | |
AU7443496A (en) | Treatment of migraine | |
AU7169096A (en) | Thrombosis treatment | |
AU5750796A (en) | System for the treatment of insomnia | |
AU6513096A (en) | Treatment of fabrics | |
AU4780596A (en) | Hemi-wheeled walker | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU7905894A (en) | Treatment of poultry | |
AUPN271295A0 (en) | Method of treatment | |
EP0813540A4 (en) | Bacterial catabolism of chitin | |
AU6200596A (en) | Disinfection apparatus | |
AU6267596A (en) | Inactivation of non-enveloped virus | |
AU7717396A (en) | Inactivation of pathogens using hydroxymethylamines | |
AU5119296A (en) | Magnetotherapy unit | |
AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
AU7318396A (en) | Methods of preserving microorganisms | |
AU4546096A (en) | Treatment of waste | |
AU6829696A (en) | Treatment of solutions | |
AU1586295A (en) | Modification of filamentous microorganisms | |
AU8266691A (en) | Method of disinfection | |
GB9526174D0 (en) | Bacterial decontamination of foods | |
AU6171196A (en) | Therapeutic uses of ta99 | |
AU5419894A (en) | Dental treatment aid | |
AU3215395A (en) | Carbapenem compounds, compositions and methods of treatment |